Goldman Sachs’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-208,028
| Closed | -$5.63M | – | 6154 |
|
|
2024
Q2 | $5.63M | Sell |
208,028
-651,153
| -76% | -$13.5M | ﹤0.01% | 3043 |
|
|
2024
Q1 | $15.7M | Sell |
859,181
-1,151,802
| -57% | -$18.3M | ﹤0.01% | 2040 |
|
|
2023
Q4 | $24.7M | Buy |
2,010,983
+1,762,048
| +708% | +$16.5M | ﹤0.01% | 1717 |
|
|
2023
Q3 | $3.73M | Buy |
248,935
+144,939
| +139% | +$3.02M | ﹤0.01% | 3250 |
|
|
2023
Q2 | $3.38M | Sell |
103,996
-8,210
| -7% | -$300K | ﹤0.01% | 3442 |
|
|
2023
Q1 | $4.39M | Sell |
112,206
-36,083
| -24% | -$1.76M | ﹤0.01% | 3183 |
|
|
2022
Q4 | $7.84M | Buy |
148,289
+19,858
| +15% | +$967K | ﹤0.01% | 2796 |
|
|
2022
Q3 | $5.78M | Buy |
128,431
+55,789
| +77% | +$2.4M | ﹤0.01% | 3007 |
|
|
2022
Q2 | $2.64M | Buy |
72,642
+15,928
| +28% | +$579K | ﹤0.01% | 3803 |
|
|
2022
Q1 | $2.34M | Sell |
56,714
-35,443
| -38% | -$1.25M | ﹤0.01% | 4119 |
|
|
2021
Q4 | $3.93M | Buy |
92,157
+38,987
| +73% | +$1.95M | ﹤0.01% | 3645 |
|
|
2021
Q3 | $2.92M | Sell |
53,170
-1,996
| -4% | -$104K | ﹤0.01% | 3841 |
|
|
2021
Q2 | $2.64M | Sell |
55,166
-16,297
| -23% | -$830K | ﹤0.01% | 3951 |
|
|
2021
Q1 | $3.62M | Buy |
71,463
+19,352
| +37% | +$1.08M | ﹤0.01% | 3439 |
|
|
2020
Q4 | $3.28M | Sell |
52,111
-34,216
| -40% | -$2.12M | ﹤0.01% | 3347 |
|
|
2020
Q3 | $5.8M | Sell |
86,327
-140,943
| -62% | -$7.69M | ﹤0.01% | 2785 |
|
|
2020
Q2 | $9.52M | Buy |
227,270
+42,623
| +23% | +$1.64M | ﹤0.01% | 2312 |
|
|
2020
Q1 | $5.81M | Sell |
184,647
-22,998
| -11% | -$921K | ﹤0.01% | 2523 |
|
|
2019
Q4 | $8.38M | Buy |
207,645
+44,036
| +27% | +$1.54M | ﹤0.01% | 2561 |
|
|
2019
Q3 | $5.32M | Buy |
163,609
+5,267
| +3% | +$210K | ﹤0.01% | 2815 |
|
|
2019
Q2 | $7.67M | Buy |
+158,342
| New | +$6.73M | ﹤0.01% | 2557 |
|
Other funds holding SILK
Goldman Sachs's SILK Position: Q3 2024 in Review
Goldman Sachs sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 208,028 shares — an estimated $5.63M sold.
Goldman Sachs first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $24.7M in Q4 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Goldman Sachs reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Goldman Sachs sold 208,028 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $5.63M.
- Goldman Sachs first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Goldman Sachs's Silk Road Medical, Inc. Common Stock position peaked at $24.7M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.